Je-hwan C. Lee

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 185 publications

Targeting CDK7 to overcome hypomethylating agent resistance in acute myeloid leukemia.

Targeting CDK7 to overcome hypomethylating agent resistance in acute myeloid leukemia.

Journal: Blood research

Published: May 07, 2026

Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING study.

Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING study.

Journal: Haematologica

Published: April 23, 2026

Myelodysplastic Syndrome With Autoimmune Disease: Clinical and Molecular Features and Survival Outcomes.

Myelodysplastic Syndrome With Autoimmune Disease: Clinical and Molecular Features and Survival Outcomes.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 23, 2026

Myelodysplasia-Related Gene Mutation Burden Is Associated With Complete Remission After Induction Therapy in Acute Myeloid Leukemia, Not Otherwise Specified: Reclassification According to the Updated Classifications.

Myelodysplasia-Related Gene Mutation Burden Is Associated With Complete Remission After Induction Therapy in Acute Myeloid Leukemia, Not Otherwise Specified: Reclassification According to the Updated Classifications.

Journal: International journal of laboratory hematology

Published: March 03, 2026

Effectiveness and safety of inpatient rehabilitation in patients with hematologic malignancies.

Effectiveness and safety of inpatient rehabilitation in patients with hematologic malignancies.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 19, 2026

Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Real-world outcomes of ponatinib in heavily pretreated patients with chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Journal: Annals of hematology

Published: December 22, 2025

Telomere length as a prognostic biomarker in myelodysplastic syndrome treated with hypomethylating agents.

Telomere length as a prognostic biomarker in myelodysplastic syndrome treated with hypomethylating agents.

Journal: Leukemia & lymphoma

Published: December 13, 2025

Long-term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma.

Long-term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma.

Journal: In vivo (Athens, Greece)

Published: November 08, 2025

Germline DDX41 mutations in myeloid neoplasms: a comprehensive review.

Germline DDX41 mutations in myeloid neoplasms: a comprehensive review.

Journal: The Korean journal of internal medicine

Published: October 14, 2025

Optimal conditioning intensity: favorable outcome of a 3-day busulfan based regimen in younger acute myeloid leukemia patients.

Optimal conditioning intensity: favorable outcome of a 3-day busulfan based regimen in younger acute myeloid leukemia patients.

Journal: Leukemia & lymphoma

Published: October 10, 2025

Early fecal metabolomic profiling for predicting acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Early fecal metabolomic profiling for predicting acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Journal: Scientific reports

Published: September 30, 2025

Outcome of Ceftazidime/Avibactam Versus Alternative Antibiotics for Treatment of Carbapenem-Resistant Enterobacterales Bacteremia in Patients With Hematologic Malignancies.

Outcome of Ceftazidime/Avibactam Versus Alternative Antibiotics for Treatment of Carbapenem-Resistant Enterobacterales Bacteremia in Patients With Hematologic Malignancies.

Journal: Journal of Korean medical science

Published: September 09, 2025

Showing 1-12 of 185

Last Updated: 09/26/2026